{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:52:02Z","timestamp":1791355922283,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.diabet.2012.12.005","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T20:46:38Z","timestamp":1363898798000},"page":"250-257","source":"Crossref","is-referenced-by-count":49,"title":["Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance"],"prefix":"10.1016","volume":"39","author":[{"given":"L.","family":"Gu\u00e9nette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.diabet.2012.12.005_bib0005","first-page":"S1","article-title":"Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada","volume":"32","year":"2008","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabet.2012.12.005_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12927\/hcq..16941","article-title":"Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes","volume":"8","author":"Wahl","year":"2005","journal-title":"Healthc Q"},{"key":"10.1016\/j.diabet.2012.12.005_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.diabet.2012.12.005_bib0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1185\/030079906X96263","article-title":"Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis","volume":"22","author":"Balkrishnan","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabet.2012.12.005_bib0025","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2337\/diacare.24.8.1411","article-title":"Utilization of oral hypoglycemic agents in a drug-insured U.S. population","volume":"24","author":"Boccuzzi","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.12.005_bib0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0149-2918(99)80023-X","article-title":"Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus","volume":"21","author":"Brown","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabet.2012.12.005_bib0035","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archinte.161.8.1106","article-title":"Predictors of persistence of use of the novel antidiabetic agent acarbose","volume":"161","author":"Catalan","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabet.2012.12.005_bib0040","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0149-2918(01)80110-7","article-title":"Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus","volume":"23","author":"Dailey","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabet.2012.12.005_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/147323000203000111","article-title":"Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients","volume":"30","author":"Dailey","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1016\/j.diabet.2012.12.005_bib0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/00044011-200222090-00002","article-title":"A \u2018Real-World\u2019 analysis of persistence on and adherence to glipizide GITS, glipizide IR and glibenclamide in managed care among patients with type 2 diabetes mellitus","volume":"22","author":"Harley","year":"2002","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.diabet.2012.12.005_bib0055","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.clinthera.2005.07.009","article-title":"Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance","volume":"27","author":"Hertz","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabet.2012.12.005_bib0060","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1185\/03007990802336335","article-title":"Effect of non-persistent use of oral glucose-lowering drugs on HbA1c goal attainment","volume":"24","author":"Penning-van Beest","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabet.2012.12.005_bib0065","first-page":"491","article-title":"Persistence patterns with oral hypoglycemic agents in type 2 diabetes","volume":"9","author":"Stephens","year":"2002","journal-title":"J Clin Outcomes Manag"},{"key":"10.1016\/j.diabet.2012.12.005_bib0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1472-6963-7-51","article-title":"Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics","volume":"7","author":"van Dijk","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.diabet.2012.12.005_bib0075","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1524-4733.2010.00761.x","article-title":"Persistence patterns with oral antidiabetes drug treatment in newly treated patient: a population-based study","volume":"13","author":"Gr\u00e9goire","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.diabet.2012.12.005_bib0080","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1503\/cmaj.080547","article-title":"Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs","volume":"180","author":"Perez","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.diabet.2012.12.005_bib0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/JOM.0b013e31816ed011","article-title":"The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization","volume":"50","author":"Colombi","year":"2008","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.diabet.2012.12.005_bib0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1464-5491.2002.00689.x","article-title":"Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study","volume":"19","author":"Donnan","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2012.12.005_bib0095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1345\/aph.1G606","article-title":"Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents","volume":"40","author":"Kalsekar","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diabet.2012.12.005_bib0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/schbul\/sbn106","article-title":"Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.diabet.2012.12.005_bib0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0149-2918(02)85047-0","article-title":"Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy","volume":"24","author":"Melikian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabet.2012.12.005_bib0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00019442-200503000-00005","article-title":"How does depression influence diabetes medication adherence in older patients?","volume":"13","author":"Kilbourne","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.diabet.2012.12.005_bib0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1464-5491.2002.00749.x","article-title":"Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes","volume":"19","author":"Evans","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2012.12.005_bib0120","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/MLR.0b013e31817924d2","article-title":"An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients","volume":"46","author":"Karve","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.diabet.2012.12.005_bib0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4093\/kdj.2010.34.1.55","article-title":"Factors that affect medication adherence in elderly patients with diabetes mellitus","volume":"34","author":"Park","year":"2010","journal-title":"Korean Diabetes J"},{"key":"10.1016\/j.diabet.2012.12.005_bib0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1463-1326.2008.00973.x","article-title":"Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study","volume":"11","author":"Donnelly","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2012.12.005_bib0135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.sapharm.2006.11.002","article-title":"Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent)","volume":"3","author":"Kalsekar","year":"2007","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.diabet.2012.12.005_bib0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2710.2002.00411.x","article-title":"Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada","volume":"27","author":"Morningstar","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.diabet.2012.12.005_bib0145","first-page":"71","article-title":"Oral antidiabetic medication adherence and glycemic control in managed care","volume":"14","author":"Rozenfeld","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.diabet.2012.12.005_bib0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1345\/aph.18198","article-title":"Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study","volume":"33","author":"Venturini","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diabet.2012.12.005_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3810\/pgm.2010.03.2128","article-title":"Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes","volume":"122","author":"Florez","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.diabet.2012.12.005_bib0160","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0895-4356(02)00400-6","article-title":"Determinants of discontinuation of new courses of antihypertensive medications","volume":"55","author":"Gr\u00e9goire","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabet.2012.12.005_bib0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0828-282X(06)70917-5","article-title":"Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort study","volume":"22","author":"Gr\u00e9goire","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.diabet.2012.12.005_bib0170","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","article-title":"The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec","volume":"48","author":"Tamblyn","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabet.2012.12.005_bib0175","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.diabet.2012.12.005_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/PPA.S10467","article-title":"A retrospective database analysis of insulin use patterns in insulin-naive patients with type 2 diabetes initiating basal insulin or mixtures","volume":"4","author":"Bonafede","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.diabet.2012.12.005_bib0185","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diabet.2012.12.005_bib0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diabet.2012.12.005_bib0195","doi-asserted-by":"crossref","first-page":"e32412","DOI":"10.1371\/journal.pone.0032412","article-title":"Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study","volume":"7","author":"Tiv","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2012.12.005_bib0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2009.08.008","article-title":"Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario","volume":"123","author":"Friedman","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.diabet.2012.12.005_bib0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.diabres.2009.11.023","article-title":"Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life","volume":"87","author":"Pollack","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2012.12.005_bib0210","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/S0149-2918(03)80347-8","article-title":"Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study","volume":"25","author":"Balkrishnan","year":"2003","journal-title":"Clin Ther"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363613000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363613000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T20:56:19Z","timestamp":1539809779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363613000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1262363613000128"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2012.12.005","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}